Page last updated: 2024-08-25

nipradilol and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole

nipradilol has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, T; Kida, T; Kojima, S; Mizuno, K; Sugiyama, T1

Other Studies

1 other study(ies) available for nipradilol and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole

ArticleYear
Involvement of nitric oxide in the ocular hypotensive action of nipradilol.
    Current eye research, 2001, Volume: 23, Issue:5

    Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anterior Chamber; Antihypertensive Agents; Aqueous Humor; Benzoates; Imidazoles; Intraocular Pressure; Nitric Oxide; Propanolamines; Rabbits; Sclera; Uvea; Vasodilator Agents

2001